Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Chen

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|November 12, 1993
(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonistsD S Dhanoa, S W Bagley, R S Chang, et al.
The Kaohsiung Journal of Medical Sciences|August 3, 2001
Surgical treatment for concomitant fractures of the femoral neck and diaphysis: a treatment protocolC H Chen, S H Hung, J C Chen, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|September 1, 1991
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonistsN B Mantlo, P K Chakravarty, D L Ondeyka, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|November 12, 1993
(Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonistsD S Dhanoa, S W Bagley, R S Chang, et al.
The Kaohsiung Journal of Medical Sciences|August 3, 2001
Surgical treatment for concomitant fractures of the femoral neck and diaphysis: a treatment protocolC H Chen, S H Hung, J C Chen, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamidesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|September 1, 1991
Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonistsN B Mantlo, P K Chakravarty, D L Ondeyka, et al.
Journal of Medicinal Chemistry|December 24, 1993
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindolesD S Dhanoa, S W Bagley, R S Chang, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadomM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|November 12, 1993
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylatesW T Ashton, S M Hutchins, W J Greenlee, et al.
Pageof 9